| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTP binding | TUBA3D TUBA1C CGAS TUBA3E RABL3 TUBA4A TUBA3C EEF1A1 EEF1A1P5 RIT2 TUBA1B TGM2 TUBA1A RHOF | 2.67e-07 | 397 | 128 | 14 | GO:0005525 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | TUBA3D TUBA1C CGAS TUBA3E RABL3 TUBA4A TUBA3C EEF1A1 EEF1A1P5 RIT2 TUBA1B TGM2 TUBA1A RHOF | 8.91e-07 | 439 | 128 | 14 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | TUBA3D TUBA1C CGAS TUBA3E RABL3 TUBA4A TUBA3C EEF1A1 EEF1A1P5 RIT2 TUBA1B TGM2 TUBA1A RHOF | 8.91e-07 | 439 | 128 | 14 | GO:0019001 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.93e-06 | 130 | 128 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | choline-phosphate cytidylyltransferase activity | 4.08e-05 | 2 | 128 | 2 | GO:0004105 | |
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 4.08e-05 | 2 | 128 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 TBC1D9B DOCK8 DOCK9 ARHGEF25 TBC1D9 ARHGAP5 ARRB1 RASGEF1C KNDC1 SIPA1L2 RHOF | 1.04e-04 | 507 | 128 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 TBC1D9B DOCK8 DOCK9 ARHGEF25 TBC1D9 ARHGAP5 ARRB1 RASGEF1C KNDC1 SIPA1L2 RHOF | 1.04e-04 | 507 | 128 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 2.43e-04 | 4 | 128 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 2.43e-04 | 4 | 128 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 3.44e-04 | 52 | 128 | 4 | GO:0042169 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 4.03e-04 | 5 | 128 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 4.03e-04 | 5 | 128 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 4.03e-04 | 5 | 128 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 4.03e-04 | 5 | 128 | 2 | GO:0000832 | |
| GeneOntologyMolecularFunction | L-serine transmembrane transporter activity | 1.43e-03 | 9 | 128 | 2 | GO:0015194 | |
| GeneOntologyMolecularFunction | structural molecule activity | CLDN18 COL12A1 TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C TUBA1B HMCN2 AEBP1 TUBA1A TUBGCP3 ERC2 SRPX | 1.74e-03 | 891 | 128 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | cytidylyltransferase activity | 1.77e-03 | 10 | 128 | 2 | GO:0070567 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | ARHGAP32 PDGFRB DOCK8 DOCK9 ARHGEF25 RABL3 RIT2 ARHGAP5 TGM2 ARRB1 RASGEF1C KNDC1 SIPA1L2 RHOF | 6.51e-06 | 538 | 128 | 14 | GO:0007264 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ARHGAP32 PDGFRB DOCK8 ARHGEF25 RABL3 RIT2 ARHGAP5 TGM2 ARRB1 SIPA1L2 RHOF | 7.47e-06 | 333 | 128 | 11 | GO:0051056 |
| GeneOntologyBiologicalProcess | inositol metabolic process | 2.71e-05 | 10 | 128 | 3 | GO:0006020 | |
| GeneOntologyCellularComponent | microtubule | GLYAT TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A TUBGCP3 PDE4DIP CEP295 DNAH6 | 1.26e-04 | 533 | 130 | 12 | GO:0005874 |
| Domain | Alpha_tubulin | 5.96e-12 | 9 | 123 | 6 | IPR002452 | |
| Domain | - | 2.59e-09 | 20 | 123 | 6 | 3.30.1330.20 | |
| Domain | - | 3.61e-09 | 21 | 123 | 6 | 1.10.287.600 | |
| Domain | Tubulin_C | 4.94e-09 | 22 | 123 | 6 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 4.94e-09 | 22 | 123 | 6 | IPR018316 | |
| Domain | - | 4.94e-09 | 22 | 123 | 6 | 3.40.50.1440 | |
| Domain | Tubulin_C | 4.94e-09 | 22 | 123 | 6 | SM00865 | |
| Domain | Tub_FtsZ_C | 6.65e-09 | 23 | 123 | 6 | IPR008280 | |
| Domain | Tubulin_C | 6.65e-09 | 23 | 123 | 6 | IPR023123 | |
| Domain | TUBULIN | 6.65e-09 | 23 | 123 | 6 | PS00227 | |
| Domain | Tubulin | 6.65e-09 | 23 | 123 | 6 | IPR000217 | |
| Domain | Tubulin | 6.65e-09 | 23 | 123 | 6 | SM00864 | |
| Domain | Tubulin_CS | 6.65e-09 | 23 | 123 | 6 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 8.81e-09 | 24 | 123 | 6 | IPR003008 | |
| Domain | Tubulin | 8.81e-09 | 24 | 123 | 6 | PF00091 | |
| Domain | Mtc | 4.25e-04 | 5 | 123 | 2 | PF03820 | |
| Domain | Mtc | 4.25e-04 | 5 | 123 | 2 | IPR004686 | |
| Domain | DUF3398 | 6.34e-04 | 6 | 123 | 2 | PF11878 | |
| Domain | Acid_Pase_AS | 6.34e-04 | 6 | 123 | 2 | IPR033379 | |
| Domain | DOCK_C/D_N | 6.34e-04 | 6 | 123 | 2 | IPR021816 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 8.84e-04 | 7 | 123 | 2 | PS00778 | |
| Domain | CTP_transf_like | 8.84e-04 | 7 | 123 | 2 | PF01467 | |
| Domain | Cyt_trans-like | 8.84e-04 | 7 | 123 | 2 | IPR004821 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 8.84e-04 | 7 | 123 | 2 | PS00616 | |
| Domain | His_Pase_clade-2 | 1.17e-03 | 8 | 123 | 2 | IPR000560 | |
| Domain | His_Phos_2 | 1.17e-03 | 8 | 123 | 2 | PF00328 | |
| Domain | DHR-1_domain | 2.28e-03 | 11 | 123 | 2 | IPR027007 | |
| Domain | DHR_2 | 2.28e-03 | 11 | 123 | 2 | PS51651 | |
| Domain | DHR_1 | 2.28e-03 | 11 | 123 | 2 | PS51650 | |
| Domain | DHR-2 | 2.28e-03 | 11 | 123 | 2 | PF06920 | |
| Domain | DOCK | 2.28e-03 | 11 | 123 | 2 | IPR026791 | |
| Domain | DUF1220 | 2.28e-03 | 11 | 123 | 2 | PF06758 | |
| Domain | NBPF_dom | 2.28e-03 | 11 | 123 | 2 | IPR010630 | |
| Domain | DOCK_C | 2.28e-03 | 11 | 123 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 2.28e-03 | 11 | 123 | 2 | PF14429 | |
| Domain | DHR-2 | 2.28e-03 | 11 | 123 | 2 | IPR027357 | |
| Domain | NBPF | 2.28e-03 | 11 | 123 | 2 | PS51316 | |
| Domain | fn3 | 4.39e-03 | 162 | 123 | 5 | PF00041 | |
| Domain | GRAM | 4.86e-03 | 16 | 123 | 2 | SM00568 | |
| Domain | MAM | 5.48e-03 | 17 | 123 | 2 | SM00137 | |
| Domain | MAM | 6.14e-03 | 18 | 123 | 2 | PF00629 | |
| Domain | Lig_chan-Glu_bd | 6.14e-03 | 18 | 123 | 2 | PF10613 | |
| Domain | Glu/Gly-bd | 6.14e-03 | 18 | 123 | 2 | IPR019594 | |
| Domain | MAM_dom | 6.14e-03 | 18 | 123 | 2 | IPR000998 | |
| Domain | Lig_chan-Glu_bd | 6.14e-03 | 18 | 123 | 2 | SM00918 | |
| Domain | Iontro_rcpt | 6.14e-03 | 18 | 123 | 2 | IPR001320 | |
| Domain | Iono_rcpt_met | 6.14e-03 | 18 | 123 | 2 | IPR001508 | |
| Domain | MAM_2 | 6.14e-03 | 18 | 123 | 2 | PS50060 | |
| Domain | Lig_chan | 6.14e-03 | 18 | 123 | 2 | PF00060 | |
| Domain | PBPe | 6.14e-03 | 18 | 123 | 2 | SM00079 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 8.04e-12 | 28 | 94 | 8 | M47898 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 8.60e-12 | 17 | 94 | 7 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.40e-11 | 18 | 94 | 7 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.21e-11 | 19 | 94 | 7 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.21e-11 | 19 | 94 | 7 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 3.37e-11 | 20 | 94 | 7 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 3.37e-11 | 20 | 94 | 7 | M47911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 3.49e-11 | 33 | 94 | 8 | M47901 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 5.03e-11 | 21 | 94 | 7 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 5.03e-11 | 21 | 94 | 7 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 7.34e-11 | 22 | 94 | 7 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 1.05e-10 | 23 | 94 | 7 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.05e-10 | 23 | 94 | 7 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.05e-10 | 23 | 94 | 7 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.47e-10 | 24 | 94 | 7 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.47e-10 | 24 | 94 | 7 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.04e-10 | 25 | 94 | 7 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.04e-10 | 25 | 94 | 7 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 2.77e-10 | 26 | 94 | 7 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.77e-10 | 26 | 94 | 7 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 3.46e-10 | 43 | 94 | 8 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 5.08e-10 | 45 | 94 | 8 | M47670 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 6.47e-10 | 29 | 94 | 7 | M27948 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.37e-09 | 32 | 94 | 7 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.37e-09 | 32 | 94 | 7 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 1.73e-09 | 33 | 94 | 7 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.70e-09 | 35 | 94 | 7 | M47774 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.72e-09 | 55 | 94 | 8 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 3.15e-09 | 56 | 94 | 8 | M2333 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 4.98e-09 | 38 | 94 | 7 | M14981 | |
| Pathway | KEGG_GAP_JUNCTION | PDGFRB TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C ADCY9 TUBA1B TUBA1A | 8.00e-09 | 90 | 94 | 9 | M4013 |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 1.24e-08 | 43 | 94 | 7 | M47773 | |
| Pathway | REACTOME_AGGREPHAGY | 1.46e-08 | 44 | 94 | 7 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.46e-08 | 44 | 94 | 7 | M27934 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 2.02e-08 | 46 | 94 | 7 | M27828 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.20e-08 | 49 | 94 | 7 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.26e-08 | 51 | 94 | 7 | M26972 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 5.61e-08 | 53 | 94 | 7 | M27651 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 6.88e-08 | 17 | 94 | 5 | MM14731 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 9.42e-08 | 57 | 94 | 7 | M27251 | |
| Pathway | REACTOME_KINESINS | 1.52e-07 | 61 | 94 | 7 | M977 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.01e-07 | 94 | 94 | 8 | M2843 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.18e-07 | 95 | 94 | 8 | M6729 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 4.39e-07 | 71 | 94 | 7 | M39690 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 4.84e-07 | 72 | 94 | 7 | M26954 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 7.03e-07 | 76 | 94 | 7 | M48037 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 7.03e-07 | 76 | 94 | 7 | M27215 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 8.51e-07 | 27 | 94 | 5 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 8.51e-07 | 27 | 94 | 5 | MM15674 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 9.17e-07 | 79 | 94 | 7 | M27743 | |
| Pathway | REACTOME_AUTOPHAGY | TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C EEF1A1 TUBA1B TUBA1A BECN1 | 1.05e-06 | 158 | 94 | 9 | M27935 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.24e-06 | 29 | 94 | 5 | MM15219 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.49e-06 | 54 | 94 | 6 | M27482 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | DOCK8 TUBA3D DOCK9 TUBA1C TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A | 1.93e-06 | 170 | 94 | 9 | M941 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.07e-06 | 32 | 94 | 5 | MM14730 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.23e-06 | 90 | 94 | 7 | M29841 | |
| Pathway | REACTOME_AGGREPHAGY | 3.79e-06 | 36 | 94 | 5 | MM15669 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 3.95e-06 | 98 | 94 | 7 | M776 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 4.36e-06 | 37 | 94 | 5 | MM15102 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.52e-06 | 100 | 94 | 7 | M27650 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 5.16e-06 | 102 | 94 | 7 | M27648 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 7.00e-06 | 150 | 94 | 8 | M27440 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 7.36e-06 | 151 | 94 | 8 | M550 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 8.28e-06 | 20 | 94 | 4 | MM1383 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | TUBA3D TUBA1C TUBA3E GRIA2 TUBA4A TUBA3C ADCY9 TUBA1B TUBA1A | 8.92e-06 | 205 | 94 | 9 | M752 |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 1.02e-05 | 113 | 94 | 7 | M27471 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.05e-05 | 44 | 94 | 5 | MM14606 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.21e-05 | 116 | 94 | 7 | MM15715 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.59e-05 | 121 | 94 | 7 | M872 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.62e-05 | 48 | 94 | 5 | MM15353 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 2.07e-05 | 126 | 94 | 7 | M705 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.18e-05 | 127 | 94 | 7 | M27181 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.40e-05 | 52 | 94 | 5 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 2.40e-05 | 52 | 94 | 5 | MM15211 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.97e-05 | 90 | 94 | 6 | MM14979 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 3.08e-05 | 134 | 94 | 7 | M27751 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 3.47e-05 | 187 | 94 | 8 | M961 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 3.56e-05 | 137 | 94 | 7 | MM15182 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 3.73e-05 | 138 | 94 | 7 | M29805 | |
| Pathway | REACTOME_KINESINS | 3.77e-05 | 57 | 94 | 5 | MM15714 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 3.80e-05 | 94 | 94 | 6 | MM14515 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 4.09e-05 | 140 | 94 | 7 | M27550 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 5.60e-05 | 200 | 94 | 8 | M864 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 5.80e-05 | 201 | 94 | 8 | M27472 | |
| Pathway | WP_ALZHEIMERS_DISEASE | TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C TUBA1B PPP3CC TUBA1A BECN1 | 6.01e-05 | 261 | 94 | 9 | M42565 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 6.43e-05 | 204 | 94 | 8 | M4217 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 7.08e-05 | 105 | 94 | 6 | MM15206 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 7.68e-05 | 66 | 94 | 5 | MM17074 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | TUBA3D TUBA1C TUBA3E GRIA2 TUBA4A TUBA3C ADCY9 TUBA1B TUBA1A | 7.80e-05 | 270 | 94 | 9 | M15514 |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 8.12e-05 | 156 | 94 | 7 | M27097 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 8.86e-05 | 68 | 94 | 5 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 8.86e-05 | 68 | 94 | 5 | MM14968 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.03e-04 | 162 | 94 | 7 | M29804 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.24e-04 | 73 | 94 | 5 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.24e-04 | 73 | 94 | 5 | MM15672 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 1.51e-04 | 16 | 94 | 3 | MM15605 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 2.18e-04 | 18 | 94 | 3 | M225 | |
| Pathway | REACTOME_MACROAUTOPHAGY | 2.30e-04 | 130 | 94 | 6 | MM14627 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP32 DOCK8 TUBA3D DOCK9 TUBA1C TUBA3E ARHGEF25 TUBA4A TUBA3C TUBA1B ARHGAP5 TUBA1A CTTN RHOF | 2.83e-04 | 720 | 94 | 14 | M41838 |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.85e-04 | 191 | 94 | 7 | M29614 | |
| Pubmed | 3.65e-16 | 9 | 133 | 7 | 21167302 | ||
| Pubmed | 4.94e-13 | 19 | 133 | 7 | 15698476 | ||
| Pubmed | 4.94e-13 | 19 | 133 | 7 | 15691386 | ||
| Pubmed | 1.66e-12 | 22 | 133 | 7 | 28117675 | ||
| Pubmed | 4.54e-12 | 6 | 133 | 5 | 3785200 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 4.21e-11 | 8 | 133 | 5 | 16148047 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 1.98e-10 | 22 | 133 | 6 | 23826228 | |
| Pubmed | 2.04e-10 | 4 | 133 | 4 | 18400243 | ||
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 5.88e-10 | 12 | 133 | 5 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 9.52e-10 | 13 | 133 | 5 | 10908577 | |
| Pubmed | 1.48e-09 | 14 | 133 | 5 | 12486001 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 3.05e-09 | 6 | 133 | 4 | 7651436 | |
| Pubmed | 3.05e-09 | 6 | 133 | 4 | 16327313 | ||
| Pubmed | 4.52e-09 | 17 | 133 | 5 | 17360745 | ||
| Pubmed | 7.09e-09 | 7 | 133 | 4 | 36681692 | ||
| Pubmed | 7.09e-09 | 7 | 133 | 4 | 11146551 | ||
| Pubmed | 1.90e-08 | 22 | 133 | 5 | 15103018 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 2.54e-08 | 9 | 133 | 4 | 11953448 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 11163133 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 5.47e-08 | 3 | 133 | 3 | 9722999 | |
| Pubmed | 7.92e-08 | 94 | 133 | 7 | 36584595 | ||
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 18613978 | ||
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 12090300 | ||
| Pubmed | 1.16e-06 | 21 | 133 | 4 | 16079250 | ||
| Pubmed | 1.70e-06 | 212 | 133 | 8 | 23463506 | ||
| Pubmed | 2.95e-06 | 58 | 133 | 5 | 27869233 | ||
| Pubmed | 4.52e-06 | 9 | 133 | 3 | 19103752 | ||
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 5.87e-06 | 116 | 133 | 6 | 22810585 | |
| Pubmed | TUBA1C KHDRBS2 TUBA3E TUBA4A TUBA3C NDUFS1 EEF1A1 EEF1A1P5 SFXN1 TUBA1B TUBA1A OXSR1 CTTN VAT1 | 7.34e-06 | 878 | 133 | 14 | 37223481 | |
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 8.82e-06 | 11 | 133 | 3 | 20405035 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 9.02e-06 | 125 | 133 | 6 | 36030824 | |
| Pubmed | ARHGAP32 DOCK8 TUBA1C GRIA2 TUBA4A NDUFS1 DDX6 EEF1A1 ARHGAP5 TUBA1A PDE4DIP SFXN3 KNDC1 OSBPL10 ERC2 SIPA1L2 CTTN DNAH6 | 9.19e-06 | 1431 | 133 | 18 | 37142655 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.04e-05 | 271 | 133 | 8 | 32433965 | |
| Pubmed | 1.06e-05 | 75 | 133 | 5 | 31527668 | ||
| Pubmed | 1.13e-05 | 76 | 133 | 5 | 27542412 | ||
| Pubmed | 1.21e-05 | 277 | 133 | 8 | 30745168 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 10480912 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 18981179 | ||
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 1.45e-05 | 2 | 133 | 2 | 24268707 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 24988431 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 28126903 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 25328666 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 12054644 | ||
| Pubmed | Structural features and restricted expression of a human alpha-tubulin gene. | 1.45e-05 | 2 | 133 | 2 | 3839072 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 24528868 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 10821867 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 17702752 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 12062403 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 22296162 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 32186954 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 26165797 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 17690096 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 12842190 | ||
| Pubmed | 1.52e-05 | 13 | 133 | 3 | 14697242 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK8 TUBA1C TUBA4A DDX6 TUBA1B INTS6 MORF4L1 TUBGCP3 HLTF OXSR1 CTTN | 1.57e-05 | 582 | 133 | 11 | 20467437 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KHDRBS2 NDUFS1 DDX6 EEF1A1 SFXN1 INTS6 TUBA1A MORF4L1 TUBGCP3 SFXN3 CSTF1 SRPX PPIP5K2 SIPA1L2 TOP2B | 1.78e-05 | 1082 | 133 | 15 | 38697112 |
| Pubmed | ARHGAP32 WDR4 TUBA1C TUT7 TUBA4A CCNB3 RASGEF1C ERC2 SIPA1L2 FTSJ3 | 2.25e-05 | 496 | 133 | 10 | 31343991 | |
| Pubmed | TUT7 AKAP3 RNF213 ICE1 KIAA1191 NDUFS1 ADCY9 TGM2 NEO1 CEP295 PPIP5K2 VAT1 | 2.64e-05 | 733 | 133 | 12 | 34672954 | |
| Pubmed | TUBA3E TUBA4A TUBA3C NDUFS1 NBPF1 EEF1A1 TUBA1B TUBA1A NBPF10 TIMELESS | 2.99e-05 | 513 | 133 | 10 | 25798074 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 3.19e-05 | 317 | 133 | 8 | 17620599 | |
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 3.33e-05 | 95 | 133 | 5 | 27129302 | |
| Pubmed | 3.69e-05 | 97 | 133 | 5 | 22360420 | ||
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 3.87e-05 | 98 | 133 | 5 | 21942715 | |
| Pubmed | 3.96e-05 | 239 | 133 | 7 | 23246001 | ||
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 3.97e-05 | 327 | 133 | 8 | 15592455 | |
| Pubmed | TUT7 GPAM TUBA4A SBNO2 TGM2 TUBGCP3 HLTF STARD3 OSBPL10 TIMELESS PPIP5K2 | 4.30e-05 | 650 | 133 | 11 | 38777146 | |
| Pubmed | ATM-CHK2-Beclin 1 axis promotes autophagy to maintain ROS homeostasis under oxidative stress. | 4.34e-05 | 3 | 133 | 2 | 32187724 | |
| Pubmed | Identification of alpha-tubulin as an hsp105alpha-binding protein by the yeast two-hybrid system. | 4.34e-05 | 3 | 133 | 2 | 12749852 | |
| Pubmed | PPIP5K2 and PCSK1 are Candidate Genetic Contributors to Familial Keratoconus. | 4.34e-05 | 3 | 133 | 2 | 31852976 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 31767681 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 12087096 | ||
| Pubmed | The N-terminal region of GAP regulates cytoskeletal structure and cell adhesion. | 4.34e-05 | 3 | 133 | 2 | 8344248 | |
| Pubmed | [Functional analysis of molecules involved in synaptic plasticity in the cerebellum]. | 4.34e-05 | 3 | 133 | 2 | 21089334 | |
| Pubmed | Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. | 4.34e-05 | 3 | 133 | 2 | 19996108 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 12464600 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 8566014 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 19409876 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 11082048 | ||
| Pubmed | Expression of human alpha-tubulin genes: interspecies conservation of 3' untranslated regions. | 4.34e-05 | 3 | 133 | 2 | 6646120 | |
| Pubmed | 4.69e-05 | 102 | 133 | 5 | 11214970 | ||
| Pubmed | 4.80e-05 | 52 | 133 | 4 | 20114047 | ||
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 4.87e-05 | 247 | 133 | 7 | 39238192 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 6.10e-05 | 256 | 133 | 7 | 24189400 | |
| Pubmed | PCYT1A TUBA1C NDUFS1 SFXN1 INTS6 PRDM10 TUBGCP3 HLTF TIMELESS CPVL | 6.22e-05 | 560 | 133 | 10 | 35241646 | |
| Pubmed | 6.91e-05 | 21 | 133 | 3 | 36332009 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ARHGAP32 DOCK9 RABL3 ADCY9 NEO1 AFAP1L2 PTPRJ PTPRM OSBPL10 VAT1 | 7.09e-05 | 569 | 133 | 10 | 30639242 |
| Pubmed | 7.75e-05 | 266 | 133 | 7 | 19380743 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 8.23e-05 | 363 | 133 | 8 | 14691545 | |
| Pubmed | Nuclear cGAS suppresses DNA repair and promotes tumorigenesis. | 8.67e-05 | 4 | 133 | 2 | 30356214 | |
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 21945077 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 28555754 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 23769926 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 15798219 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 20204303 | ||
| Pubmed | Cortactin regulates endo-lysosomal sorting of AMPARs via direct interaction with GluA2 subunit. | 8.67e-05 | 4 | 133 | 2 | 29515177 | |
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 18187866 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 12024216 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 9372968 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 17389232 | ||
| Interaction | TCP11L2 interactions | 3.37e-09 | 21 | 131 | 6 | int:TCP11L2 | |
| Interaction | TUBGCP2 interactions | 2.28e-06 | 176 | 131 | 9 | int:TUBGCP2 | |
| Interaction | GRM7 interactions | 6.13e-06 | 19 | 131 | 4 | int:GRM7 | |
| Interaction | CDC42 interactions | PCYT1A ARHGAP32 DOCK8 DOCK9 TUBA1C AGR2 GRIA2 ARHGEF25 RABL3 NDUFS1 ADCY9 DDX6 SFXN1 TUBA1B ARHGAP5 ARRB1 PTPRJ TUBA1A SYNE2 SFXN3 OSBPL10 RHOF TOP2B | 1.35e-05 | 1323 | 131 | 23 | int:CDC42 |
| Interaction | LTA interactions | 3.09e-05 | 28 | 131 | 4 | int:LTA | |
| Interaction | NSUN5P1 interactions | 4.06e-05 | 59 | 131 | 5 | int:NSUN5P1 | |
| Interaction | MALRD1 interactions | 4.19e-05 | 2 | 131 | 2 | int:MALRD1 | |
| Interaction | RAC1 interactions | PCYT1A ARHGAP32 PDGFRB DOCK8 DOCK9 GRIA2 ARHGEF25 TUBA4A NDUFS1 ADCY9 EEF1A1 SFXN1 TUBA1B ARHGAP5 PTPRJ PTPRM TUBA1A OSBPL10 OXSR1 | 5.76e-05 | 1063 | 131 | 19 | int:RAC1 |
| Interaction | EML1 interactions | 6.03e-05 | 33 | 131 | 4 | int:EML1 | |
| Interaction | GABRA1 interactions | 6.18e-05 | 152 | 131 | 7 | int:GABRA1 | |
| Cytoband | 12q13.12 | 1.86e-04 | 38 | 133 | 3 | 12q13.12 | |
| GeneFamily | Tubulins | 2.41e-11 | 26 | 85 | 7 | 778 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.76e-06 | 23 | 85 | 4 | 662 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.11e-04 | 161 | 85 | 6 | 593 | |
| GeneFamily | Sideroflexins | 2.16e-04 | 5 | 85 | 2 | 746 | |
| GeneFamily | Fibronectin type III domain containing | 9.46e-04 | 160 | 85 | 5 | 555 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 1.65e-03 | 13 | 85 | 2 | 1146 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.33e-03 | 21 | 85 | 2 | 813 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP | 8.82e-07 | 200 | 133 | 9 | M4630 | |
| Coexpression | HAEGERSTRAND_RESPONSE_TO_IMATINIB | 1.05e-05 | 9 | 133 | 3 | M16300 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-07 | 161 | 133 | 7 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-07 | 161 | 133 | 7 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-07 | 161 | 133 | 7 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.23e-06 | 181 | 133 | 7 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.38e-06 | 184 | 133 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.53e-06 | 187 | 133 | 7 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 189 | 133 | 7 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.89e-06 | 193 | 133 | 7 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 2.09e-06 | 196 | 133 | 7 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-06 | 197 | 133 | 7 | 8b3bf5b45e49bf1c60e4d2703b470bb890385f67 | |
| ToppCell | (6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.39e-06 | 200 | 133 | 7 | f0818821c495022569aef2c1886d9f2446dc027e | |
| ToppCell | (6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.39e-06 | 200 | 133 | 7 | f9baef67dde62f1c161a9408a78f635ea70ea9d3 | |
| ToppCell | severe_influenza-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 9.34e-06 | 162 | 133 | 6 | 7137990e6e1473665911e39a22092a05ae25ce74 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.34e-06 | 162 | 133 | 6 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 173 | 133 | 6 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 173 | 133 | 6 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-05 | 178 | 133 | 6 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-05 | 178 | 133 | 6 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | Mild-Lymphoid-T-innate_T|Mild / Condition, Lineage, Cell class and cell subclass | 1.65e-05 | 179 | 133 | 6 | abc0fbe101a464a2c85755a974a3d5c2b968fe46 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.75e-05 | 181 | 133 | 6 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-05 | 184 | 133 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.92e-05 | 184 | 133 | 6 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-05 | 184 | 133 | 6 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-05 | 186 | 133 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 187 | 133 | 6 | 908df5520142d65fe32a003d26be14965082a1ea | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 187 | 133 | 6 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 187 | 133 | 6 | c1dfab0b0d7f519b9f13f4e0365ab41c4b2ae1ec | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 187 | 133 | 6 | b486cc5ac678051fea9d4c7db53b26a5a8427e60 | |
| ToppCell | severe_influenza-CD4+_Tcm|severe_influenza / disease group, cell group and cell class (v2) | 2.17e-05 | 188 | 133 | 6 | 633e5545f49b1b864b0ffa5fc9688d270690f884 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 189 | 133 | 6 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 189 | 133 | 6 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 190 | 133 | 6 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 191 | 133 | 6 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 194 | 133 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-05 | 194 | 133 | 6 | 4c40d6b50675eae52c419d69e719a9223df02ae3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 194 | 133 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-05 | 194 | 133 | 6 | ca1f24070424b44b7a442e4fca761ebfbe24b063 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-05 | 194 | 133 | 6 | 99a90de637e3babec2131cdd9f05ea965d8a8f30 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 2.67e-05 | 195 | 133 | 6 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | 18-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 2.67e-05 | 195 | 133 | 6 | e0ee7905499ee1a1ca7b1184e2713028cf156985 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 195 | 133 | 6 | e10b21e4dba4483efc4c82d6e395524246ca14a8 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 2.67e-05 | 195 | 133 | 6 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.67e-05 | 195 | 133 | 6 | 6ddce0cce14f737e45b8f57802c6a8ad07686262 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.67e-05 | 195 | 133 | 6 | e6212373cc3c6c98f76e104e2ac1afa68965cc5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 195 | 133 | 6 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | Mild_COVID-19-T/NK-CD4+_T_2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.74e-05 | 196 | 133 | 6 | e50d03d8428dc4526e4607b6b4e99f0812a0ad31 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 196 | 133 | 6 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 196 | 133 | 6 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 196 | 133 | 6 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.74e-05 | 196 | 133 | 6 | c4e7133c609bcbc48c4947ea0aa1a7d9d7251b04 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.74e-05 | 196 | 133 | 6 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.74e-05 | 196 | 133 | 6 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.74e-05 | 196 | 133 | 6 | 40cae477b3906623d1f2a4c630279e710499ce80 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 197 | 133 | 6 | bc6c530330907a5ec823cc243c8e9c9e340cfb9c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 197 | 133 | 6 | d14e1f2ba94240c61eac435db43508a224d606a8 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.82e-05 | 197 | 133 | 6 | 9acf6719126ca335f584811a72b46af485d67437 | |
| ToppCell | Control-Lymphoid-CD4_T_cells|Control / Condition, Lineage and Cell class | 2.82e-05 | 197 | 133 | 6 | dad6479caac07c1536f2b3082a51d61ae08beca0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 197 | 133 | 6 | 77fe092aae8f05fe137680506892d2f61071d6ea | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 197 | 133 | 6 | 02e70768a917c5f097bc653e9e965a1000289d2e | |
| ToppCell | droplet-Bladder-BLADDER|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 197 | 133 | 6 | 5ae84f796005fa7b75d10b6464770da6cd5c8f53 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8|Lung / Manually curated celltypes from each tissue | 2.82e-05 | 197 | 133 | 6 | b2f5b35e931c1342e541ecf05933350c41612415 | |
| ToppCell | CV-Severe-0|Severe / Virus stimulation, Condition and Cluster | 2.82e-05 | 197 | 133 | 6 | d13fc20b31ab6d9117437fba319c72f3a552858f | |
| ToppCell | droplet-Bladder-BLADDER-1m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 197 | 133 | 6 | 1e24150c5146c93914aaaa981bd17589e8ed7cf9 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.82e-05 | 197 | 133 | 6 | 82eab092d075507889fe1d8845c754a7f0bed30a | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 197 | 133 | 6 | 036c4c9b3ae80e2dc21c24a84504d3da0541f945 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.82e-05 | 197 | 133 | 6 | 56afed433887cb2766eb30f22aec195148db33ab | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.90e-05 | 198 | 133 | 6 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 198 | 133 | 6 | 1b9200e30f1d9b91bb0c6411c4f95208aedbe161 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 198 | 133 | 6 | 8f202ed4692ea2c139ff05d4805c704ee4be095c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 198 | 133 | 6 | 77288df94286382170a266474ab85960519e8449 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 198 | 133 | 6 | 2ee195f20a4f91fa1dcad9eaf96d6086e3b0fb4a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 198 | 133 | 6 | 54c8aa47040bc4977eed382514fc4ceae03f54f8 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 198 | 133 | 6 | 55378e15360f867c9500b03293814965562ae55d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 198 | 133 | 6 | 7e2d6e21b2b3d5a4a9f786890ec6ba2688a506cc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 198 | 133 | 6 | daf367b699726286f0f0f7b4f3a6cf70c462fbeb | |
| ToppCell | medial-2-Endothelial-Artery|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.99e-05 | 199 | 133 | 6 | 53c17c0493f82351a039bc64def191311e0f4951 | |
| ToppCell | medial-Endothelial-Artery-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.99e-05 | 199 | 133 | 6 | c455f5a2802f2ec6f0e24266de1aaf3203ca8c78 | |
| ToppCell | Severe_COVID-19-T/NK|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.99e-05 | 199 | 133 | 6 | ace179b860513179e9275ed40ae1985a98385026 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.99e-05 | 199 | 133 | 6 | c8a2c94809b2134b51bb9868b63cb280b490f3fe | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 199 | 133 | 6 | ed460ff7fb82d3f0eed689d56f50d40514f74b48 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-05 | 199 | 133 | 6 | bfc157be6e9f84739848eb19b718de5b17f3fa88 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 199 | 133 | 6 | 20f760d92c351a1dac4cc0a424c443ea03a179fe | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-05 | 199 | 133 | 6 | c007cd51577e31553395ceaed70ad447e5854546 | |
| ToppCell | medial-Endothelial-Artery|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.99e-05 | 199 | 133 | 6 | 341c0be18bec66f4cc8bda232dce54edb34b9cda | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-05 | 199 | 133 | 6 | 28cec7122b143373f1c7c94acf35bf8f896e0d57 | |
| ToppCell | 3'-GW_trimst-1.5|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-05 | 199 | 133 | 6 | 8e69d718ed5b05b08550973c33c92f0c6bfccc68 | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-05 | 200 | 133 | 6 | 5c0135d3cb6f7fa904e9760904dfe5f11c7e9102 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | COVID-19-Lymphoid|COVID-19 / Condition, Lineage and Cell class | 3.07e-05 | 200 | 133 | 6 | 4408304fd43c6e329b0d7e131f1759e7f2932299 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_CTL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 200 | 133 | 6 | b76f000582b38f4c61b44081eba9ae213382cb6f | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 200 | 133 | 6 | 3e0041c04e42a47257517dae8707a6454570c256 | |
| ToppCell | medial-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-05 | 200 | 133 | 6 | 16b00eacbea4d75cf814803d3fc0b82c2b8c0a9c | |
| ToppCell | proximal-mesenchymal-Vascular_Smooth_Muscle|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-05 | 200 | 133 | 6 | 22892afca3666e944102c231b3f10340d8391364 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 15-Airway|15 / Age, Tissue, Lineage and Cell class | 3.07e-05 | 200 | 133 | 6 | ba4b8d5becf81351901c2ecac74ffa28e29586f3 | |
| ToppCell | proximal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-05 | 200 | 133 | 6 | 870ab11343711f64fe6d6a858fc420fe17f1636a | |
| Drug | Epothilone D | 4.31e-09 | 12 | 130 | 5 | DB01873 | |
| Drug | Epothilone B | 4.31e-09 | 12 | 130 | 5 | DB03010 | |
| Drug | azatoxin | 7.14e-07 | 30 | 130 | 5 | CID000125383 | |
| Drug | citostal | 7.14e-07 | 30 | 130 | 5 | CID000018991 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 7.25e-07 | 4 | 130 | 3 | DB07574 | |
| Drug | guanine | IGFN1 WDR4 DOCK9 TUBA1C TUBA3E GRIA2 GRID2 ARHGEF25 RABL3 TUBA4A ADCY9 EEF1A1 RIT2 TGM2 ARRB1 TUBA1A RASGEF1C C5AR1 RHOF | 9.02e-07 | 902 | 130 | 19 | CID000000764 |
| Drug | AAGTP | 1.76e-06 | 64 | 130 | 6 | CID000656407 | |
| Drug | AC1O5Y0F | 2.11e-06 | 37 | 130 | 5 | CID006442852 | |
| Drug | lumicolchicine | 3.57e-06 | 41 | 130 | 5 | CID000072624 | |
| Drug | epo906 | 4.17e-06 | 114 | 130 | 7 | CID000388945 | |
| Drug | bromocolchicine | 5.63e-06 | 21 | 130 | 4 | CID000161518 | |
| Drug | colchifoline | 5.63e-06 | 21 | 130 | 4 | CID000100132 | |
| Drug | Ustiloxin A | 5.63e-06 | 21 | 130 | 4 | CID000164454 | |
| Drug | SRI-3072 | 5.63e-06 | 21 | 130 | 4 | CID000493469 | |
| Drug | C20:1n-9 | 6.26e-06 | 7 | 130 | 3 | CID000142770 | |
| Drug | 3,4,5-trimethoxyacetophenone | 6.85e-06 | 22 | 130 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 6.85e-06 | 22 | 130 | 4 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 6.85e-06 | 22 | 130 | 4 | CID000098538 | |
| Drug | SureCN13401588 | 6.85e-06 | 22 | 130 | 4 | CID009897422 | |
| Drug | N-methyldemecolcine | 6.85e-06 | 22 | 130 | 4 | CID000023759 | |
| Drug | NSC-339672 | 6.85e-06 | 22 | 130 | 4 | CID000433930 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 8.26e-06 | 23 | 130 | 4 | CID000006858 | |
| Drug | AC1L2P05 | 8.26e-06 | 23 | 130 | 4 | CID000125688 | |
| Drug | 2,3,4-tabp | 8.26e-06 | 23 | 130 | 4 | CID000125548 | |
| Drug | NSC-373301 | 8.26e-06 | 23 | 130 | 4 | CID000341375 | |
| Drug | NSC355636 | 8.26e-06 | 23 | 130 | 4 | CID000100176 | |
| Drug | IKP104 | 8.26e-06 | 23 | 130 | 4 | CID000130739 | |
| Drug | fluorescein-colchicine | 8.26e-06 | 23 | 130 | 4 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 8.26e-06 | 23 | 130 | 4 | CID000084076 | |
| Drug | 2,3,4-TCB | 8.26e-06 | 23 | 130 | 4 | CID000129239 | |
| Drug | N-acetylcolchinol | 8.26e-06 | 23 | 130 | 4 | CID000097865 | |
| Drug | parbendazole | 9.87e-06 | 24 | 130 | 4 | CID000026596 | |
| Drug | tropolone methyl ether | 9.87e-06 | 24 | 130 | 4 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 9.87e-06 | 24 | 130 | 4 | CID000330401 | |
| Drug | NABV | 9.87e-06 | 24 | 130 | 4 | CID000175959 | |
| Drug | AC1L4TG7 | 9.87e-06 | 24 | 130 | 4 | CID000163705 | |
| Drug | moscatilin | 9.87e-06 | 24 | 130 | 4 | CID000176096 | |
| Drug | NSC-36768 | 9.87e-06 | 24 | 130 | 4 | CID000165441 | |
| Drug | deacetamidocolchicine | 9.87e-06 | 24 | 130 | 4 | CID000014995 | |
| Drug | colchicide | 9.87e-06 | 24 | 130 | 4 | CID000120712 | |
| Drug | 2-(N-morpholino)ethanesulfonic acid | 9.98e-06 | 86 | 130 | 6 | CID000078165 | |
| Drug | TK-B | 1.07e-05 | 51 | 130 | 5 | CID000009074 | |
| Drug | mpMap | 1.17e-05 | 25 | 130 | 4 | CID000100806 | |
| Drug | AC1Q6P06 | 1.17e-05 | 25 | 130 | 4 | CID000160263 | |
| Drug | allocolchicine | 1.17e-05 | 25 | 130 | 4 | CID000196989 | |
| Drug | 1069C85 | 1.17e-05 | 25 | 130 | 4 | CID006918099 | |
| Drug | 55623-37-5 | 1.17e-05 | 25 | 130 | 4 | CID006438440 | |
| Drug | MDL 27048 | 1.17e-05 | 25 | 130 | 4 | CID006439188 | |
| Drug | NBD-colcemid | 1.17e-05 | 25 | 130 | 4 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 1.17e-05 | 25 | 130 | 4 | CID000043264 | |
| Drug | CA1P | 1.17e-05 | 25 | 130 | 4 | CID006918545 | |
| Drug | peloruside A | 1.17e-05 | 25 | 130 | 4 | CID006918506 | |
| Drug | NSC142227 | 1.17e-05 | 25 | 130 | 4 | CID000073427 | |
| Drug | magnesium sulfate | 1.18e-05 | 52 | 130 | 5 | CID000024083 | |
| Drug | tropolone | 1.29e-05 | 53 | 130 | 5 | CID000010789 | |
| Drug | NSC527981 | 1.38e-05 | 26 | 130 | 4 | CID000352796 | |
| Drug | NSC332029 | 1.38e-05 | 26 | 130 | 4 | CID000100073 | |
| Drug | indibulin | 1.38e-05 | 26 | 130 | 4 | CID000002929 | |
| Drug | pironetin | 1.38e-05 | 26 | 130 | 4 | CID006438891 | |
| Drug | isaxonine | 1.38e-05 | 26 | 130 | 4 | CID000071169 | |
| Drug | AC1L1J4H | 1.61e-05 | 27 | 130 | 4 | CID000004862 | |
| Drug | dinitroanilines | 1.61e-05 | 27 | 130 | 4 | CID000136400 | |
| Drug | NSC292222 | 1.61e-05 | 27 | 130 | 4 | CID000099957 | |
| Drug | NSC D-669356 | 1.61e-05 | 27 | 130 | 4 | CID000178028 | |
| Drug | NSC 370147 | 1.87e-05 | 28 | 130 | 4 | CID000182762 | |
| Drug | NSC72302 | 1.87e-05 | 28 | 130 | 4 | CID000118078 | |
| Drug | bp U | 2.16e-05 | 29 | 130 | 4 | CID000368697 | |
| Drug | oxibendazole | 2.16e-05 | 29 | 130 | 4 | CID000004622 | |
| Drug | Aids106696 | 2.16e-05 | 29 | 130 | 4 | CID006475933 | |
| Drug | ddGDP | 2.16e-05 | 29 | 130 | 4 | CID000134739 | |
| Drug | AC1NBBHE | 2.48e-05 | 30 | 130 | 4 | CID004490620 | |
| Drug | eleutherobin | 2.48e-05 | 30 | 130 | 4 | CID006918335 | |
| Drug | NSC617668 | 2.48e-05 | 30 | 130 | 4 | CID000357989 | |
| Drug | thiocolchicine | 2.48e-05 | 30 | 130 | 4 | CID000017648 | |
| Drug | plumbagin | 2.59e-05 | 61 | 130 | 5 | CID000010205 | |
| Drug | Taxane | 2.80e-05 | 103 | 130 | 6 | CID000108169 | |
| Drug | NSC609395 | 2.83e-05 | 31 | 130 | 4 | CID005488798 | |
| Drug | amiprophosmethyl | 2.83e-05 | 31 | 130 | 4 | CID000100524 | |
| Drug | AC7700 | 2.83e-05 | 31 | 130 | 4 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 2.83e-05 | 31 | 130 | 4 | CID000032851 | |
| Drug | tropone | 2.83e-05 | 31 | 130 | 4 | CID000010881 | |
| Drug | AC1L3V8I | 2.83e-05 | 31 | 130 | 4 | CID000122777 | |
| Drug | NSC332598 | 2.83e-05 | 31 | 130 | 4 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 2.83e-05 | 31 | 130 | 4 | CID000023678 | |
| Drug | AC1L1G95 | 3.22e-05 | 32 | 130 | 4 | CID000003583 | |
| Drug | NSC153858 | 3.22e-05 | 32 | 130 | 4 | CID000547450 | |
| Drug | E2-3,4-Q | 3.22e-05 | 32 | 130 | 4 | CID000067402 | |
| Drug | 2-demethylcolchicine | 3.22e-05 | 32 | 130 | 4 | CID000023757 | |
| Drug | PMME | 3.24e-05 | 2 | 130 | 2 | CID000439436 | |
| Drug | 7-((9-fluorenylmethoxycarbonyl)cyclohexylalanyllysyl)amino-4-methylcoumarin | 3.24e-05 | 2 | 130 | 2 | ctd:C456547 | |
| Drug | PIPES | 3.27e-05 | 64 | 130 | 5 | CID000079723 | |
| Drug | mebendazole | 3.65e-05 | 33 | 130 | 4 | CID000004030 | |
| Drug | CA4P | 3.65e-05 | 33 | 130 | 4 | CID000370232 | |
| Drug | taltobulin | 3.65e-05 | 33 | 130 | 4 | CID006918637 | |
| Drug | triethyllead | 4.12e-05 | 34 | 130 | 4 | CID006328106 | |
| Drug | NSC376450 | 4.12e-05 | 34 | 130 | 4 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 4.12e-05 | 34 | 130 | 4 | CID000161091 | |
| Drug | vindesine | 4.39e-05 | 68 | 130 | 5 | CID000040839 | |
| Drug | discodermolide | 4.63e-05 | 35 | 130 | 4 | CID000643668 | |
| Drug | HU-211 | 4.97e-05 | 114 | 130 | 6 | CID000107778 | |
| Disease | microlissencephaly (implicated_via_orthology) | 1.84e-16 | 8 | 127 | 7 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 1.84e-16 | 8 | 127 | 7 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 1.84e-16 | 8 | 127 | 7 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 1.91e-11 | 27 | 127 | 7 | DOID:0050453 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement | TBC1D9B KHDRBS2 RNF213 GPAM CUBN TM6SF2 CDH20 HMCN2 ST8SIA6 PTPRJ CHEK2 ERC2 CMAHP VAT1 | 3.65e-05 | 904 | 127 | 14 | EFO_0004736 |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 5.50e-05 | 3 | 127 | 2 | DOID:0080463 (implicated_via_orthology) | |
| Disease | nephrotic syndrome type 20 (implicated_via_orthology) | 1.10e-04 | 4 | 127 | 2 | DOID:0070357 (implicated_via_orthology) | |
| Disease | Huntington disease, disease progression measurement | 2.90e-04 | 30 | 127 | 3 | EFO_0008336, MONDO_0007739 | |
| Disease | disease recurrence, malaria | 5.06e-04 | 8 | 127 | 2 | EFO_0001068, EFO_0004952 | |
| Disease | level of Ceramide (d40:1) in blood serum | 9.86e-04 | 11 | 127 | 2 | OBA_2045185 | |
| Disease | Schizophrenia | ARHGAP32 PDGFRB GRIA2 NDUFS1 SBNO2 TGM2 PPP3CC TRPM1 OXSR1 FXYD1 BECN1 | 1.55e-03 | 883 | 127 | 11 | C0036341 |
| Disease | revision of total hip arthroplasty | 1.62e-03 | 14 | 127 | 2 | EFO_0020973 | |
| Disease | immature platelet measurement | 1.77e-03 | 119 | 127 | 4 | EFO_0803541 | |
| Disease | FEV/FEC ratio | CLDN18 DOCK9 TUT7 KHDRBS2 RIT2 PTPRM SYNE2 RASGEF1C ERC2 C5AR1 CTTN CPVL TOP2B | 2.49e-03 | 1228 | 127 | 13 | EFO_0004713 |
| Disease | acute lymphoblastic leukemia | 2.92e-03 | 66 | 127 | 3 | EFO_0000220 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.00e-03 | 19 | 127 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.00e-03 | 19 | 127 | 2 | C2936783 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 3.60e-03 | 71 | 127 | 3 | EFO_0004735, EFO_0007965 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 3.82e-03 | 239 | 127 | 5 | EFO_0010934 | |
| Disease | nucleotide measurement | 3.89e-03 | 73 | 127 | 3 | EFO_0010513 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YETTDKHLSPDGQYV | 111 | O95994 | |
| EYEGITPELKHYFTE | 261 | Q68DN1 | |
| AYDATHLVKSYPGSQ | 201 | P10768 | |
| KSLYVAEYHSEPVED | 466 | P26196 | |
| KPKSEHVVSEFGDSY | 256 | Q86VW2 | |
| YHGYVEAAPESLVVF | 111 | Q9UKJ8 | |
| YRVTAHAEGYTPSAK | 951 | Q8IUX7 | |
| PVYTDETLHSTTGEY | 366 | Q9UKB5 | |
| SGSKTDPEEFTYDYV | 446 | Q8N4X5 | |
| EETKTHGPYVITGDY | 71 | Q8N0U6 | |
| YTTPDYGHYDDKDTL | 6 | P21730 | |
| YGHYDDKDTLDLNTP | 11 | P21730 | |
| GPKNSYIAYIEDHSG | 151 | O96017 | |
| TGSYYEHVKISAPNE | 211 | Q8N884 | |
| ASLDKEIYYHGEPIS | 201 | P49407 | |
| VPFLEHYSGYSISEL | 1321 | Q8WWL7 | |
| RVHDYKEGTPEEKTY | 46 | Q5HYI8 | |
| YVSNSAKYSELGHPF | 351 | Q9UL03 | |
| TAIELATGAAPYHKY | 216 | O95747 | |
| SASDYEVAPPEYHRK | 346 | Q9UBU8 | |
| DSDKYSVFPTLRGYH | 186 | P28039 | |
| KSPDGASEYVYHLVI | 561 | Q12913 | |
| YHTPEKDKVVSAFYT | 266 | Q6IF00 | |
| VGSHEDPAVYTYATL | 301 | P46095 | |
| FVYSYAVEKPLSVGH | 331 | Q8N468 | |
| GDYVVGTDPSKHYIS | 216 | Q96T55 | |
| EETAIYKGDYSATHP | 946 | Q15034 | |
| HPGYLAYEEIAATSS | 176 | Q8NDA2 | |
| KLGFPVYSHVDYSNE | 256 | Q6IB77 | |
| YYHPGTDSKIIITDF | 226 | P11801 | |
| VPYGNHSYLESLTDK | 331 | Q14457 | |
| TGESYAGKYVPAIAH | 201 | Q9H3G5 | |
| EEKEYPGAHTTTIKY | 281 | P42262 | |
| EIPYGTVLDSAVYEH | 676 | O43424 | |
| IPYSSAGSDDVYKHI | 171 | P49585 | |
| IPYSSAGSDDVYKHI | 171 | Q9Y5K3 | |
| TAHYPTPAELDAYAK | 36 | Q8WU58 | |
| ESPKEHDPFTYDYQS | 21 | O00168 | |
| LASAVHAYTKTGDPY | 396 | Q96CW5 | |
| ATYTISITHPKEYGA | 241 | Q07075 | |
| PMYLSDHEGVASTTY | 61 | O15083 | |
| ASYTSVDGPEHTLVY | 56 | Q9NQV6 | |
| GYTPHKGLTTEETKY | 131 | Q96A73 | |
| EPVSYHNSGVKYAAS | 1916 | A7KAX9 | |
| PYGSSFYALEEKHVG | 1076 | Q3BBV0 | |
| EEALSAHYSEVPYGD | 646 | Q68CR7 | |
| DDPSTSVGAYHYMLE | 136 | Q8N485 | |
| TAKGHYLYIESSEPQ | 906 | Q5VYJ5 | |
| VYIHDADSAGYVTSP | 2221 | O60494 | |
| HELPTYGDSEKMTYT | 411 | Q9C0G6 | |
| ASDHTYYNSKLEPSG | 1536 | Q9Y2F5 | |
| YDSSSHLATVEKYEP | 491 | Q6TDP4 | |
| TAVTYHNKSPDFYEE | 616 | Q8NF50 | |
| AEPYVASEYKTVHEE | 921 | Q9BZ29 | |
| YDFKPASIDTSSEGY | 36 | Q96CJ1 | |
| SYHITYKEAAGDDEV | 661 | Q99715 | |
| EYTGTDPLYVGKLHS | 71 | Q9HBT6 | |
| ETSKYYVTIIDAPGH | 81 | P68104 | |
| PALAVYSHVTSEYET | 876 | O60503 | |
| ETSKYYVTIIDAPGH | 81 | Q5VTE0 | |
| GHGVSEDAYDSYAPE | 306 | Q5VWX1 | |
| SAVLYHTEVAYDPEG | 486 | Q68CP4 | |
| TSEKGPYFLTEYSTH | 1456 | Q76NI1 | |
| SDKYEVYVSPDGLTH | 351 | Q86VF2 | |
| YNILTHDYGTKGDSP | 531 | Q14527 | |
| ASEYETCYVTSHKGP | 96 | Q05048 | |
| SYAVEEEHAYLGPTV | 1931 | Q9C0D2 | |
| PEETNYKAVSYHASG | 201 | P56856 | |
| SVSSDGHEYIYVDPM | 571 | P09619 | |
| TSYKIGHLDPDTEYE | 336 | P28827 | |
| SVGYVDSHPITTYDS | 46 | Q95460 | |
| GHEGYVPSSYLVEKS | 216 | Q08881 | |
| YYSDSDKHQGSGVPS | 71 | A0A075B6I7 | |
| GTKEDLHLPSTNYYV | 396 | Q6NUM9 | |
| TADKYHVVSGADDYT | 131 | Q8TED0 | |
| EHYAPSVFEKYTASV | 46 | Q9HBH0 | |
| KYVYDSAFHPDTGEK | 71 | Q9BWM7 | |
| HDKGYLSDYVGPSSV | 36 | Q9BWW7 | |
| AKYIYDSAFHPDTGE | 71 | Q9H9B4 | |
| TPALISDYKEYHTDT | 971 | Q02880 | |
| HASSYISPEKEEQYI | 271 | P78395 | |
| HEEDEEGPYYSALSG | 6431 | Q8WXH0 | |
| QPYGSSFYALEEKHV | 1536 | Q6P3W6 | |
| PYGSSFYALEEKHVG | 1781 | Q6P3W6 | |
| QPYGSSFYALEEKHV | 2756 | Q6P3W6 | |
| PYGSSFYALEEKHVG | 3001 | Q6P3W6 | |
| QPYGSSFYALEEKHV | 1021 | A0A087WUL8 | |
| PYGSSFYALEEKHVG | 1266 | A0A087WUL8 | |
| QPYGSSFYALEEKHV | 2241 | A0A087WUL8 | |
| PYGSSFYALEEKHVG | 2486 | A0A087WUL8 | |
| QPYGSSFYALEEKHV | 3461 | A0A087WUL8 | |
| PYGSSFYALEEKHVG | 3706 | A0A087WUL8 | |
| QPYGSSFYALEEKHV | 921 | P0DPF2 | |
| PYGSSFYALEEKHVG | 1166 | P0DPF2 | |
| QPYGSSFYALEEKHV | 2141 | P0DPF2 | |
| PYGSSFYALEEKHVG | 2386 | P0DPF2 | |
| QPYGSSFYALEEKHV | 3361 | P0DPF2 | |
| PYGSSFYALEEKHVG | 3606 | P0DPF2 | |
| QPYGSSFYALEEKHV | 4506 | P0DPF2 | |
| PYGSSFYALEEKHVG | 4826 | P0DPF2 | |
| VDLTYTYDHLGDSPK | 436 | P28331 | |
| PDYHDPTIEDAYKTQ | 46 | Q99578 | |
| KYPSHSFIGEESVAA | 61 | P29218 | |
| VEEGTNHSAKYPDLY | 426 | Q7RTY7 | |
| IDVSYLPHSSEYSVG | 11 | Q9HCL2 | |
| PHGDNLTYSVFYTKE | 466 | Q92859 | |
| PKAEGYAEGDLTLYH | 236 | Q8IY81 | |
| PDDEPAKLYSVHGYA | 1306 | Q9P2F8 | |
| FSKTVEDIPVSHHYY | 346 | P61647 | |
| LGHTETYADYVPSKS | 196 | Q9Y2G9 | |
| HVSVPKGASYSDDIY | 921 | Q8IZU2 | |
| ADEYYPEHTSVLSTI | 46 | Q13017 | |
| DDEVGYSHPRYKDTP | 41 | P78539 | |
| LEHGEEYVFTLPSAY | 581 | Q9BXB5 | |
| IDKTIAYGYIHDPSG | 861 | Q9UL12 | |
| EYGDTVYTIEVPFHG | 266 | Q14849 | |
| HPGYYAELVEKSTGK | 531 | Q66K14 | |
| DPHKGFSVDYYNTTT | 76 | O75969 | |
| GYFVESHPSDKYIKE | 256 | Q9Y471 | |
| REDITHTYKYPEGSS | 436 | P21980 | |
| HTYKYPEGSSEEREA | 441 | P21980 | |
| PSEDYGNEKTLEHYT | 231 | P48454 | |
| KYSPSDVFIGYHSDA | 3211 | Q63HN8 | |
| TYAPVISAEKAYHEQ | 271 | P0DPH8 | |
| ALGYLEGDTYHKEPD | 16 | Q9UNS1 | |
| TEAVYESAEAPGHYP | 466 | Q14247 | |
| ITHYLYTAPIFSEDG | 421 | Q8N431 | |
| ADSETVHYHYGPKDL | 61 | Q15035 | |
| HYDEEYLPDASKPAS | 506 | Q6IQ55 | |
| TYAPVISAEKAYHEQ | 271 | P0DPH7 | |
| AINEKATHPGYYEDL | 531 | Q6ZT07 | |
| AEKYHVPGTGESYTL | 3236 | Q86WI1 | |
| YYSASEGTTDKGEVP | 66 | A0A0K0K1D8 | |
| KHTQSYPTDSYGVLE | 46 | Q7Z4N2 | |
| AHEKEKYQPSYDTTI | 256 | Q9NZI7 | |
| SEDYGKDYPSSENLH | 891 | Q9UJU3 | |
| HPIDYHTTDYVDEIK | 236 | Q99536 | |
| TYAPVISAEKAYHEQ | 271 | Q71U36 | |
| DKSGDVYSFSVLEPH | 121 | P57081 | |
| TYAPVISAEKAYHEQ | 271 | Q6PEY2 | |
| HGEVSYDPLYAVFAV | 56 | Q9BZW4 | |
| DVKVYTVGPDYAHAE | 246 | O43314 | |
| PYTTYLVEKGASHSF | 91 | Q5H8A4 | |
| TYAPVISAEKAYHEQ | 271 | P68363 | |
| VNSDDYKGDKVYHPE | 731 | Q5VYS8 | |
| TYAPVISAEKAYHEQ | 271 | Q9BQE3 | |
| TYTPGKGEEQELHYA | 631 | Q96RL6 | |
| TDVKVYTVGPDYAHA | 256 | Q6PFW1 | |
| YTVGPDYAHAEARKS | 261 | Q6PFW1 | |
| TYAPVISAEKAYHEQ | 271 | P68366 | |
| DTEGTAAETHYTYFP | 106 | P22415 | |
| VSEYTHYEEKKASPS | 1626 | Q5VU43 |